Home LiteratureArticle Details
PMID: 9848439 Published · ppublish English Journal Article Review

Spiramycin renaissance.

The Journal of antimicrobial chemotherapy ·Vol. 42 ·No. 5 ·1998-11-00 ·Pages 572-6

Rubinstein E, Keller N

Abstract

暂无摘要

MeSH Terms
Administration, Oral Anti-Bacterial Agents/pharmacokinetics,therapeutic use Clinical Trials as Topic Double-Blind Method Humans Prospective Studies Randomized Controlled Trials as Topic Respiratory Tract Infections/drug therapy,microbiology Spiramycin/pharmacokinetics,therapeutic use Tissue Distribution
Chemicals
Anti-Bacterial Agents Spiramycin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rubinstein E
Unit of Infectious Diseases, Chaim Sheba Medical Center, Tel Aviv University School of Medicine, Tel-Hashomer, Israel.
Keller N
Article Info
Journal
The Journal of antimicrobial chemotherapy
Abbr.
J Antimicrob Chemother
ISSN
0305-7453
DOI
10.1093/jac/42.5.572
Published
1998-11-00
Pages
572-6
Language
English
Region
England
NLM ID
7513617
Subset
IM
External Links
PubMed source DOI: 10.1093/jac/42.5.572 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2